<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:media="http://search.yahoo.com/mrss/" >

<channel>
	<title>CLX &#8211; Stock Earnings</title>
	<atom:link href="https://cms.stocksearning.com/tag/clx/feed/" rel="self" type="application/rss+xml" />
	<link>https://cms.stocksearning.com</link>
	<description>Empowering Investors and Traders</description>
	<lastBuildDate>Mon, 12 Oct 2026 15:33:19 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.4</generator>

<image>
	<url>https://cms.stocksearning.com/wp-content/uploads/2025/10/cropped-cropped-SE_lovo_bimi-32x32.jpg</url>
	<title>CLX &#8211; Stock Earnings</title>
	<link>https://cms.stocksearning.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>2 Dividend Stocks to Watch as Flu Season Gets Underway</title>
		<link>https://cms.stocksearning.com/2026/10/dividend-stocks-to-watch-flu-season/</link>
					<comments>https://cms.stocksearning.com/2026/10/dividend-stocks-to-watch-flu-season/#respond</comments>
		
		<dc:creator><![CDATA[Ian Cooper]]></dc:creator>
		<pubDate>Mon, 12 Oct 2026 15:30:00 +0000</pubDate>
				<category><![CDATA[Evergreen]]></category>
		<category><![CDATA[CLX]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[LABU]]></category>
		<category><![CDATA[mrna]]></category>
		<guid isPermaLink="false">https://cms.stocksearning.com/?p=8940</guid>

					<description><![CDATA[Any investor holding pharmacy and flu-related, coughing-sniffling remedy stocks will tell you that flu season is one of the best times of the year.]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">The 2026-2027 flu season is underway. That means it’s time to get flu shots and try your best to avoid germs.&nbsp;</p>



<div class="wp-block-rank-math-toc-block" id="rank-math-toc"><h2>Table of Contents</h2><nav><ul><li><a href="#clorox-seasonal-growth-with-a-high-yield-dividend">Clorox: Seasonal Growth With a High-Yield Dividend</a></li><li><a href="#cvs-health-benefits-from-seasonal-demand-for-flu-shots">CVS Health: Benefits From Seasonal Demand for Flu Shots</a></li><li><a href="#an-etf-for-risk-tolerant-investors">An ETF For Risk-Tolerant Investors</a></li><li><a href="#in-short">Flu Season Stock Outlook: Dividends, Earnings and Risk</a></li></ul></nav></div>



<p class="wp-block-paragraph">As anyone with a respiratory system will tell you, flu season isn’t fun. However, as any investor holding pharmacy and flu-related, coughing-sniffling remedy stocks will tell you, it’s one of the best times of the year.</p>



<p class="wp-block-paragraph">For the 2024–2025 flu season, the CDC’s March 2026 summary estimated 51 million illnesses, 710,000 hospitalizations, and 45,000 deaths in the United States. For 2025–2026, numbers covering October 1 through May 23 ranged from 32 million to 57 million illnesses, 390,000 to 800,000 hospitalizations, and 19,000 to 60,000 deaths.&nbsp;</p>



<p class="wp-block-paragraph">At the moment, the <a href="https://www.cdc.gov/flu/season/2026-2027.html" target="_blank" rel="noopener">CDC reported that flu activity remained low</a>. However, it&#8217;s increasing in many parts of the country, particularly along the West Coast.&nbsp;</p>



<p class="wp-block-paragraph">As noted by Prevention, “I’m surprised that it’s happening earlier this year,” says&nbsp;Thomas Russo, M.D., professor and chief of infectious disease at the University at Buffalo in New York. “We had a couple of bad back-to-back flu seasons, and people developed immunity that should still offer some protection—but this is happening at least four weeks earlier than usual.”</p>



<p class="wp-block-paragraph">Here are three options for investors looking to invest in flu season. </p>



<h2 id="clorox-seasonal-growth-with-a-high-yield-dividend" class="wp-block-heading">Clorox: Seasonal Growth With a High-Yield Dividend </h2>



<p class="wp-block-paragraph">With a yield of 5.97%, oversold shares of <strong><a href="https://stocksearning.com/stocks/CLX/earnings-date">Clorox (NYSE: CLX)</a></strong> are a bargain at $83.80. For one, going back to 2021, CLX tends to run higher around late October.&nbsp;</p>



<p class="wp-block-paragraph">In October 2022, CLX ran from about $112 to just over $131. In 2023, CLX ran from about $116 to about $130. In 2024, CLX ran from about $151 to $155. In 2025, it didn’t do as well as it usually does, which isn’t typical. </p>



<p class="wp-block-paragraph">However, with CLX severely oversold, investors may want to take advantage of this seasonal trend while also collecting a dividend with a yield of around 6%. <a href="https://stocksearning.com/stocks/CLX">Clorox will pay a dividend of $1.25</a> on November 13 to shareholders of record as of October 28.</p>



<figure class="wp-block-image size-large"><img fetchpriority="high" decoding="async" width="600" height="315" data-source="article-image" src="https://cms.stocksearning.com/wp-content/uploads/2026/10/CLX_2026-10-12_09-57-06-600x315.png" alt="flu - StockEarnings" class="wp-image-8968" srcset="https://cms.stocksearning.com/wp-content/uploads/2026/10/CLX_2026-10-12_09-57-06-600x315.png 600w, https://cms.stocksearning.com/wp-content/uploads/2026/10/CLX_2026-10-12_09-57-06-300x158.png 300w, https://cms.stocksearning.com/wp-content/uploads/2026/10/CLX_2026-10-12_09-57-06-767x403.png 767w, https://cms.stocksearning.com/wp-content/uploads/2026/10/CLX_2026-10-12_09-57-06.png 1439w" sizes="(max-width: 600px) 100vw, 600px" /></figure>



<h2 id="cvs-health-benefits-from-seasonal-demand-for-flu-shots" class="wp-block-heading">CVS Health: Benefits From Seasonal Demand for Flu Shots</h2>



<p class="wp-block-paragraph"><strong><a href="https://stocksearning.com/stocks/CVS/earnings-date">CVS Health (NYSE: CVS)</a></strong> may be one of the best &#8220;pure plays&#8221; on flu season. CVS could be worth buying ahead of the busiest stretch of flu season, as demand for vaccinations, prescriptions, and over-the-counter remedies could bring more customers through its doors. The company is already offering updated 2026–2027 flu vaccines at CVS Pharmacy and Minute Clinic locations nationwide, positioning it to capture that seasonal business.&nbsp;</p>



<p class="wp-block-paragraph">In 2022, CVS ran from about $76 in October to about $89 by December. In 2023, it ran from $62 to $70.84. In 2024, it ran from about $56 to about $61.In 2025, it ran from about $73 to $77.</p>



<p class="wp-block-paragraph">CVS Health is also an <a href="https://stocksearning.com/stocks/CVS">attractive dividend payer with a yield of about 3.1%</a>. CVS will pay a dividend of just over 66 cents per share on November 2 to shareholders of record as of October 22.</p>



<p class="wp-block-paragraph">Beyond flu season, CVS’s improving earnings strengthen the investment case. Following a strong second quarter, management raised its 2026 adjusted earnings outlook to $7.90 to $8.10 per share, supported by better results in its pharmacy and Aetna insurance businesses.&nbsp;</p>



<figure class="wp-block-image size-large"><img decoding="async" width="600" height="315" data-source="article-image" src="https://cms.stocksearning.com/wp-content/uploads/2026/10/CVS_2026-10-12_09-58-53-600x315.png" alt="flu - StockEarnings" class="wp-image-8967" srcset="https://cms.stocksearning.com/wp-content/uploads/2026/10/CVS_2026-10-12_09-58-53-600x315.png 600w, https://cms.stocksearning.com/wp-content/uploads/2026/10/CVS_2026-10-12_09-58-53-300x158.png 300w, https://cms.stocksearning.com/wp-content/uploads/2026/10/CVS_2026-10-12_09-58-53-767x403.png 767w, https://cms.stocksearning.com/wp-content/uploads/2026/10/CVS_2026-10-12_09-58-53.png 1438w" sizes="(max-width: 600px) 100vw, 600px" /></figure>



<h2 id="an-etf-for-risk-tolerant-investors" class="wp-block-heading">An ETF For Risk-Tolerant Investors</h2>



<p class="wp-block-paragraph">We can also look at the <strong>Direxion Daily S&amp;P Biotech Bull 3x Shares ETF (NYSEARCA: LABU)</strong>, which seeks 300% of the performance of the S&amp;P Biotechnology Select Industry Index. The ETF holds flu stocks, such as <strong><a href="https://stocksearning.com/stocks/MRNA">Moderna (NASDAQ: MRNA)</a></strong>. And when market commentary highlights rising flu or respiratory illness cases, it can draw short-term attention to the ETF.&nbsp;</p>



<p class="wp-block-paragraph">In 2022, it ran from about $147 in October to a high of $181 by February. In 2023, it ran from $64 to about $132. In 2024, it ran from about $119 to $150. In 2025, it ran from about $93 to a high of $182.</p>



<figure class="wp-block-image size-large"><img decoding="async" width="600" height="315" data-source="article-image" src="https://cms.stocksearning.com/wp-content/uploads/2026/10/LABU_2026-10-12_09-56-36-600x315.png" alt="flu - StockEarnings" class="wp-image-8965" srcset="https://cms.stocksearning.com/wp-content/uploads/2026/10/LABU_2026-10-12_09-56-36-600x315.png 600w, https://cms.stocksearning.com/wp-content/uploads/2026/10/LABU_2026-10-12_09-56-36-300x158.png 300w, https://cms.stocksearning.com/wp-content/uploads/2026/10/LABU_2026-10-12_09-56-36-767x403.png 767w, https://cms.stocksearning.com/wp-content/uploads/2026/10/LABU_2026-10-12_09-56-36.png 1439w" sizes="(max-width: 600px) 100vw, 600px" /></figure>



<h2 id="in-short" class="wp-block-heading">Flu Season Stock Outlook: Dividends, Earnings and Risk</h2>



<p class="wp-block-paragraph">Flu season could give investors another reason to look at Clorox and CVS, particularly if stronger seasonal demand helps support their broader businesses. But the real investment case needs to last beyond the winter months. Earnings growth, dependable cash flow and sustainable dividends will ultimately matter more than a temporary increase in sales of disinfectants, vaccines or cold remedies.</p>



<p class="wp-block-paragraph">LABU requires a different approach. It targets three times its biotechnology index’s&nbsp;daily&nbsp;performance, making it a more aggressive trading vehicle. Its leverage magnifies potential losses, and returns over longer periods can differ substantially from three times the index’s overall return.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://cms.stocksearning.com/2026/10/dividend-stocks-to-watch-flu-season/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>3 High-Yield Dividend ETFs to Protect Your Portfolio</title>
		<link>https://cms.stocksearning.com/2026/09/dividend-etfs-to-protect-portfolio/</link>
					<comments>https://cms.stocksearning.com/2026/09/dividend-etfs-to-protect-portfolio/#respond</comments>
		
		<dc:creator><![CDATA[Ian Cooper]]></dc:creator>
		<pubDate>Tue, 08 Sep 2026 13:45:00 +0000</pubDate>
				<category><![CDATA[Evergreen]]></category>
		<category><![CDATA[ABBV]]></category>
		<category><![CDATA[AFL]]></category>
		<category><![CDATA[AMGN]]></category>
		<category><![CDATA[AVGO]]></category>
		<category><![CDATA[BRK.B]]></category>
		<category><![CDATA[CAT]]></category>
		<category><![CDATA[CLX]]></category>
		<category><![CDATA[CSCO]]></category>
		<category><![CDATA[CVX]]></category>
		<category><![CDATA[GD]]></category>
		<category><![CDATA[HD]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[JPM]]></category>
		<category><![CDATA[NOBL]]></category>
		<category><![CDATA[PNR]]></category>
		<category><![CDATA[SCHD]]></category>
		<category><![CDATA[SCHV]]></category>
		<category><![CDATA[wmt]]></category>
		<category><![CDATA[XOM]]></category>
		<guid isPermaLink="false">https://cms.stocksearning.com/?p=7131</guid>

					<description><![CDATA[In times of chaos, dividend ETFs can offer investors a compelling mix of stability, passive income, and long-term growth. ]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">In times of chaos, dividend ETFs can offer investors a compelling mix of stability, passive income, and long-term growth. And when markets get rocky, funds focused on companies with a history of raising their dividends can provide an added layer of resilience. In fact, if safety and income are high on your checklist,&nbsp;start with Dividend Aristocrats and Dividend Kings.</p>



<div class="wp-block-rank-math-toc-block" id="rank-math-toc"><h2>Table of Contents</h2><nav><ul><li><a href="#what-are-dividend-aristocrats-and-dividend-kings">What Are Dividend Aristocrats and Dividend Kings?</a></li><li><a href="#why-dividend-growth-matters">Why Dividend Growth Matters for Income Investors?</a></li><li><a href="#theres-one-problem-for-investors">Dividend ETFs Offer Diversification and Income</a></li><li><a href="#pro-shares-s-p-500-dividend-aristocrats-etf-bats-nobl">NOBL Offers Direct Exposure to Dividend Aristocrats</a></li><li><a href="#schwab-u-s-large-cap-value-etf-nysearca-schv">SCHV Combines Large-Cap Value With Low Costs</a></li><li><a href="#schwab-u-s-dividend-equity-etf-nysearca-schd">SCHD Targets Quality Dividend-Paying Companies</a></li><li><a href="#which-etf-is-right-for-you">Which Dividend ETF Is Right for Your Portfolio?</a></li><li><a href="#why-dividend-et-fs-can-strengthen-a-long-term-portfolio">Why Dividend ETFs Can Strengthen a Long-Term Portfolio</a></li></ul></nav></div>



<h2 id="what-are-dividend-aristocrats-and-dividend-kings" class="wp-block-heading">What Are Dividend Aristocrats and Dividend Kings?</h2>



<p class="wp-block-paragraph">Dividend Aristocrats are some of the most consistent dividend-paying companies in the stock market. To qualify as a Dividend Aristocrat, a company must have increased its dividend for at least&nbsp;25 consecutive years.</p>



<p class="wp-block-paragraph">Dividend Kings take things a step further. These elite companies have raised their dividends for&nbsp;at least 50 consecutive years. That&#8217;s an impressive record.</p>



<p class="wp-block-paragraph">Think about everything that can happen to a business over five decades: recessions, inflation, rising interest rates, market crashes, technological changes and economic booms. Companies that continue increasing their dividends through all of that have demonstrated an unusual level of financial strength and resilience.</p>



<h2 id="why-dividend-growth-matters" class="wp-block-heading">Why Dividend Growth Matters for Income Investors?</h2>



<p class="wp-block-paragraph">For income-focused investors, a dividend isn&#8217;t necessarily valuable just because it&#8217;s large.</p>



<p class="wp-block-paragraph">A company that consistently&nbsp;grows its dividend&nbsp;can be even more attractive.</p>



<p class="wp-block-paragraph">Over time, rising dividend payments can help investors generate a growing stream of passive income. Dividend growth can also provide some protection against inflation by increasing the amount of income an investment produces.</p>



<p class="wp-block-paragraph">Of course, past performance doesn&#8217;t guarantee future results. But a company that has successfully increased its dividend for decades has already demonstrated an ability to navigate challenging economic environments.</p>



<h2 id="theres-one-problem-for-investors" class="wp-block-heading">Dividend ETFs Offer Diversification and Income</h2>



<p class="wp-block-paragraph">There&#8217;s a catch for anyone specifically looking for Dividend Kings. There isn&#8217;t currently a dedicated ETF focused solely on Dividend Kings. That means investors wanting exposure to these companies generally have two choices: buy individual Dividend King stocks or look for ETFs that invest in companies with similar characteristics.</p>



<p class="wp-block-paragraph">That&#8217;s where dividend-focused and value-oriented ETFs can come in handy.</p>



<p class="wp-block-paragraph">Here are three worth considering.</p>



<h2 id="pro-shares-s-p-500-dividend-aristocrats-etf-bats-nobl" class="wp-block-heading">NOBL Offers Direct Exposure to Dividend Aristocrats</h2>



<p class="wp-block-paragraph">For investors who want direct exposure to companies with long dividend-growth records, NOBL is one of the most obvious choices. The ProShares S&amp;P 500 Dividend Aristocrats ETF tracks the S&amp;P 500 Dividend Aristocrats Index, investing in companies that have increased their dividends for at least 25 consecutive years. The fund has an expense ratio of 0.35% and a yield of roughly 2.14%. Its holdings include familiar names such as <strong><a href="https://stocksearning.com/stocks/CAT/earnings-date">Caterpillar (NYSE: CAT)</a></strong>, <strong><a href="https://stocksearning.com/stocks/PNR/earnings-date">Pentair (NYSE: PNR)</a></strong>, <strong><a href="https://stocksearning.com/stocks/aBBV/earnings-date">AbbVie (NYSE: ABBV)</a></strong>, <strong>Aflac (NYSE: AFL)</strong>, <strong><a href="https://stocksearning.com/stocks/gd/earnings-date">General Dynamics (NYSE: GD)</a></strong>, <strong><a href="https://stocksearning.com/stocks/CLX/earnings-date">Clorox (NYSE: CLX)</a></strong>, and <strong><a href="https://stocksearning.com/stocks/wmt/earnings-date">Walmart (NASDAQ: WMT)</a></strong>.</p>



<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="600" height="312" data-source="article-image" src="https://cms.stocksearning.com/wp-content/uploads/2026/09/NOBL_2026-09-07_12-02-11-1-600x312.png" alt="dividend etfs - StockEarnings" class="wp-image-7237" srcset="https://cms.stocksearning.com/wp-content/uploads/2026/09/NOBL_2026-09-07_12-02-11-1-600x312.png 600w, https://cms.stocksearning.com/wp-content/uploads/2026/09/NOBL_2026-09-07_12-02-11-1-300x156.png 300w, https://cms.stocksearning.com/wp-content/uploads/2026/09/NOBL_2026-09-07_12-02-11-1-768x400.png 768w, https://cms.stocksearning.com/wp-content/uploads/2026/09/NOBL_2026-09-07_12-02-11-1.png 1160w" sizes="auto, (max-width: 600px) 100vw, 600px" /></figure>



<h2 id="schwab-u-s-large-cap-value-etf-nysearca-schv" class="wp-block-heading">SCHV Combines Large-Cap Value With Low Costs</h2>



<p class="wp-block-paragraph">Rather than focusing specifically on dividend growth, the <a href="https://www.schwabassetmanagement.com/products/schv" target="_blank" rel="noopener">Schwab U.S. Large Cap Value ETF</a> invests in large-cap U.S. value stocks. That gives investors exposure to a broad collection of established companies, many of which also pay dividends. The biggest attraction may be the fund&#8217;s 0.06% expense ratio, which is extremely low. SCHV has a yield of approximately 1.8% and includes companies such as <strong>Berkshire Hathaway (NYSE: BRK.B)</strong>,<strong><a href="https://stocksearning.com/stocks/jnj/earnings-date"> Johnson &amp; Johnson (NYSE: JNJ)</a></strong>, <strong><a href="https://stocksearning.com/stocks/XOM/earnings-date">Exxon Mobil (NYSE: XOM)</a></strong>, <strong><a href="https://stocksearning.com/stocks/JPM/earnings-date">JPMorgan Chase (NYSE: JPM)</a></strong>, <strong><a href="https://stocksearning.com/stocks/HD/earnings-date">Home Depot (NYSE: HD)</a></strong>, and <strong><a href="https://stocksearning.com/stocks/abbv/earnings-date">AbbVie (NYSE: ABBV)</a></strong>, to name just a few.</p>



<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="600" height="312" data-source="article-image" src="https://cms.stocksearning.com/wp-content/uploads/2026/09/SCHV_2026-09-07_12-03-04-2-600x312.png" alt="dividend etfs - StockEarnings" class="wp-image-7239" srcset="https://cms.stocksearning.com/wp-content/uploads/2026/09/SCHV_2026-09-07_12-03-04-2-600x312.png 600w, https://cms.stocksearning.com/wp-content/uploads/2026/09/SCHV_2026-09-07_12-03-04-2-300x156.png 300w, https://cms.stocksearning.com/wp-content/uploads/2026/09/SCHV_2026-09-07_12-03-04-2-768x400.png 768w, https://cms.stocksearning.com/wp-content/uploads/2026/09/SCHV_2026-09-07_12-03-04-2.png 1160w" sizes="auto, (max-width: 600px) 100vw, 600px" /></figure>



<h2 id="schwab-u-s-dividend-equity-etf-nysearca-schd" class="wp-block-heading">SCHD Targets Quality Dividend-Paying Companies</h2>



<p class="wp-block-paragraph">There&#8217;s also&nbsp;SCHD, one of the best-known dividend ETFs for long-term income investors.</p>



<p class="wp-block-paragraph">The <a href="https://www.schwabassetmanagement.com/resource/schd-fact-sheet" target="_blank" rel="noopener">Schwab U.S. Dividend Equity ETF</a> tracks the Dow Jones U.S. Dividend 100 Index and focuses on companies with strong fundamentals, sustainable dividends and consistent payout histories.</p>



<p class="wp-block-paragraph">SCHD has an expense ratio of just 0.06% and a yield of roughly 3%. Its holdings include <strong><a href="https://stocksearning.com/stocks/amgn/earnings-date">Amgen (NASDAQ: AMGN)</a></strong>, <strong>AbbVie</strong>, <strong>Home Depot</strong>, <strong><a href="https://stocksearning.com/stocks/csco/earnings-date">Cisco Systems (NASDAQ: CSCO)</a></strong>, <strong><a href="https://stocksearning.com/stocks/avgo/earnings-date">Broadcom (NASDAQ: AVGO)</a></strong>, and <strong><a href="https://stocksearning.com/stocks/cvx/earnings-date">Chevron (NYSE: CVX)</a></strong>, to name just a few.</p>



<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="600" height="312" data-source="article-image" src="https://cms.stocksearning.com/wp-content/uploads/2026/09/SCHD_2026-09-07_12-03-41-1-600x312.png" alt="dividend etfs - StockEarnings" class="wp-image-7240" srcset="https://cms.stocksearning.com/wp-content/uploads/2026/09/SCHD_2026-09-07_12-03-41-1-600x312.png 600w, https://cms.stocksearning.com/wp-content/uploads/2026/09/SCHD_2026-09-07_12-03-41-1-300x156.png 300w, https://cms.stocksearning.com/wp-content/uploads/2026/09/SCHD_2026-09-07_12-03-41-1-768x400.png 768w, https://cms.stocksearning.com/wp-content/uploads/2026/09/SCHD_2026-09-07_12-03-41-1.png 1160w" sizes="auto, (max-width: 600px) 100vw, 600px" /></figure>



<h2 id="which-etf-is-right-for-you" class="wp-block-heading">Which Dividend ETF Is Right for Your Portfolio?</h2>



<p class="wp-block-paragraph">Each of these ETFs offers something different.</p>



<ul class="wp-block-list">
<li>NOBL&nbsp;is the most closely aligned with the Dividend Aristocrat strategy and emphasizes companies with exceptionally long dividend-growth records.</li>



<li>SCHV&nbsp;provides broader exposure to large-cap value stocks while keeping costs extremely low.</li>



<li>SCHD&nbsp;focuses more directly on dividend-paying companies and offers a combination of income, quality and potential growth.</li>
</ul>



<p class="wp-block-paragraph">The best choice depends on your goals, risk tolerance and the role you want dividends to play in your portfolio.</p>



<h2 id="why-dividend-et-fs-can-strengthen-a-long-term-portfolio" class="wp-block-heading">Why Dividend ETFs Can Strengthen a Long-Term Portfolio</h2>



<p class="wp-block-paragraph">No ETF can completely protect investors from market losses. And a high dividend yield doesn&#8217;t automatically mean an investment is safe. Still, dividend-focused ETFs can play an important role in a diversified, long-term portfolio.</p>



<p class="wp-block-paragraph">When markets become volatile, companies with decades of dividend growth can offer investors something valuable:&nbsp;a potentially growing stream of income backed by businesses that have already weathered multiple economic cycles. For investors who want exposure to that strategy without buying dozens of individual stocks,&nbsp;NOBL, SCHV and SCHD&nbsp;provide three different ways to pursue income, quality and long-term portfolio stability.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://cms.stocksearning.com/2026/09/dividend-etfs-to-protect-portfolio/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Kraft Heinz is Trying to Corner the Ranch Market – Clorox is a Better Buy </title>
		<link>https://cms.stocksearning.com/2026/06/clorox-better-buy-in-ranch-market/</link>
					<comments>https://cms.stocksearning.com/2026/06/clorox-better-buy-in-ranch-market/#respond</comments>
		
		<dc:creator><![CDATA[Chris Markoch]]></dc:creator>
		<pubDate>Fri, 26 Jun 2026 15:30:00 +0000</pubDate>
				<category><![CDATA[Evergreen]]></category>
		<category><![CDATA[Event-Based]]></category>
		<category><![CDATA[CLX]]></category>
		<category><![CDATA[KHC]]></category>
		<guid isPermaLink="false">https://cms.stocksearning.com/?p=2800</guid>

					<description><![CDATA[Kraft Heinz can give visitors a travel kit with ranch dressing. Clorox owns the brand that passive income investors are actually trying to bring home.]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">The 2026 FIFA World&nbsp;Cup is bringing&nbsp;a taste of America to many Europeans. That includes our nation’s fondness for ranch dressing. If&nbsp;you’re&nbsp;like me, you&nbsp;weren’t&nbsp;aware&nbsp;that a condiment we take for granted&nbsp;isn’t&nbsp;a “thing” in&nbsp;Europe.&nbsp;&nbsp;</p>



<div class="wp-block-rank-math-toc-block" id="rank-math-toc"><h2>Table of Contents</h2><nav><ul><li><a href="#two-high-yields-two-very-different-stories">Two High Yields, Two Very Different Stories </a></li><li><a href="#why-kraft-heinzs-high-dividend-yield-comes-with-risk">Why Kraft Heinz&#8217;s High Dividend Yield Comes With Risk</a></li><li><a href="#how-hidden-valley-ranch-could-support-clorox-stock">How Hidden Valley Ranch Could Support Clorox Stock </a></li><li><a href="#what-are-the-biggest-risks-for-clorox-stock">What Are the Biggest Risks for Clorox Stock? </a></li><li><a href="#should-investors-buy-clorox-or-kraft-heinz">Should Investors Buy Clorox or Kraft Heinz? </a></li></ul></nav></div>



<p class="wp-block-paragraph">That may be changing as many tourists are taking a taste back with them.&nbsp;&nbsp;</p>



<p class="wp-block-paragraph">But if you see the world through the eyes of an investor, as I do,&nbsp;there’s&nbsp;an opportunity happening in two stocks. One is&nbsp;<a href="https://stocksearning.com/stocks/KHC/earnings-date" target="_blank" rel="noreferrer noopener"><strong>Kraft Heinz (NYSE: KHC)</strong></a>. The company has worked&nbsp;out an&nbsp;<a href="https://www.travelpirates.com/captains-log/world-cup-fans-ranch-tsa-warning" target="_blank" rel="noreferrer noopener">arrangement with the Transportation Security Administration (TSA)</a>&nbsp;to create a ranch “travel kit.”&nbsp;&nbsp;</p>



<p class="wp-block-paragraph">As someone who&nbsp;cut&nbsp;his teeth in marketing, I appreciate the hustle. But as an investor, it still&nbsp;doesn’t&nbsp;make KHC very tasty.&nbsp;</p>



<p class="wp-block-paragraph">There is another name to&nbsp;consider,&nbsp;and it may be a surprise to many of you,&nbsp;<a href="https://stocksearning.com/stocks/CLX/earnings-date" target="_blank" rel="noreferrer noopener"><strong>Clorox (NYSE: CLX)</strong></a>. The company is the parent company of&nbsp;the Hidden&nbsp;Valley Ranch. Really, it is and has been since the early 1970s.&nbsp;The company has also been making an effort to showcase its brand.&nbsp;&nbsp;</p>



<p class="wp-block-paragraph">It’s&nbsp;a hidden part of the company’s portfolio, but it may steer some investors to take a closer look at the stock. But what will they find?&nbsp;&nbsp;</p>



<h2 id="two-high-yields-two-very-different-stories" class="wp-block-heading">Two High Yields, Two Very Different Stories&nbsp;</h2>



<p class="wp-block-paragraph">Let me get real with you for a second. I&nbsp;don’t&nbsp;advocate buying KHC or CLX as part of your growth portfolio. These stocks&nbsp;aren’t&nbsp;built for that.&nbsp;The total return in CLX over the last 10 years is poor, but KHC is worse.&nbsp;</p>



<p class="wp-block-paragraph">No, investors&nbsp;aren’t&nbsp;buying these stocks for growth. But they each have a redeeming quality, which is a high-yield dividend.&nbsp;As of the market&nbsp;close&nbsp;on June 25, the dividend for Clorox sat at 5.2%. But Kraft Heinz offered a dividend yield of 6.82%. Pretty tempting, right?&nbsp;&nbsp;</p>



<p class="wp-block-paragraph">This is one time where bigger&nbsp;isn’t&nbsp;better. By other measures, including the payout per share and the number of years of consecutive dividend growth, Clorox is the better dividend stock to own. Yes, the dividend being supported by 50% of cash flow is a bit&nbsp;steep,&nbsp;but it’s&nbsp;not alarming, and with 47 years of dividend increases, the company is just three years away from joining the elite category of&nbsp;Dividend&nbsp;Kings.&nbsp;&nbsp;</p>



<h2 id="why-kraft-heinzs-high-dividend-yield-comes-with-risk" class="wp-block-heading">Why Kraft Heinz&#8217;s High Dividend Yield Comes With Risk</h2>



<p class="wp-block-paragraph">Kraft Heinz tells a different story. The 7%-plus yield looks generous on paper.&nbsp;But KHC&#8217;s dividend has actually declined over the past decade.&nbsp;</p>



<p class="wp-block-paragraph">The company has paid $0.40 per quarter for several&nbsp;years&nbsp;running. That works out to $1.60 annually. The streak of consecutive increases sits at one year.&nbsp;</p>



<p class="wp-block-paragraph">The financials are worse. KHC posted a&nbsp;$5.85 billion&nbsp;net loss in 2025 on a 3.5% revenue decline. Full-year loss per share came in at $4.93.&nbsp;</p>



<p class="wp-block-paragraph">Berkshire Hathaway, which helped engineer the 2015 merger, took a&nbsp;$3.76 billion&nbsp;write-down on its stake last year. KHC shares&nbsp;are down&nbsp;roughly 60% from where they started after the deal closed.&nbsp;</p>



<p class="wp-block-paragraph">Management has been in turnaround mode for years. A planned spinoff announced in September 2025 was paused in February. New CEO Steve Cahillane is now directing about $600 million toward fixing the business rather than splitting it.&nbsp;</p>



<h2 id="how-hidden-valley-ranch-could-support-clorox-stock" class="wp-block-heading">How Hidden Valley Ranch Could Support Clorox Stock&nbsp;</h2>



<p class="wp-block-paragraph">Hidden Valley Ranch sits inside Clorox&#8217;s Lifestyle segment.&nbsp;It&#8217;s&nbsp;a small piece of a company best known for bleach. But&nbsp;it&#8217;s&nbsp;an underrated brand asset.&nbsp;</p>



<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="600" height="287" data-source="article-image" src="https://cms.stocksearning.com/wp-content/uploads/2026/06/Clorox_2-002-600x287.png" alt="ranch - StockEarnings " class="wp-image-2801" srcset="https://cms.stocksearning.com/wp-content/uploads/2026/06/Clorox_2-002-600x287.png 600w, https://cms.stocksearning.com/wp-content/uploads/2026/06/Clorox_2-002-300x143.png 300w, https://cms.stocksearning.com/wp-content/uploads/2026/06/Clorox_2-002-768x367.png 768w, https://cms.stocksearning.com/wp-content/uploads/2026/06/Clorox_2-002-1536x734.png 1536w, https://cms.stocksearning.com/wp-content/uploads/2026/06/Clorox_2-002.png 1915w" sizes="auto, (max-width: 600px) 100vw, 600px" /></figure>



<p class="wp-block-paragraph">The Ranch-bassador&nbsp;program&nbsp;reportedly drew&nbsp;more than 6,000 applications. Two duos are now traveling Europe, putting ranch on everything from Italian pizza to fish and chips. World Cup tourists are doing some of that marketing work for free.&nbsp;</p>



<p class="wp-block-paragraph">This&nbsp;isn&#8217;t&nbsp;going to move CLX earnings next quarter. But it plants a flag in a market that has barely heard of ranch dressing. Building brand awareness abroad is how single-country products become global ones.&nbsp;</p>



<p class="wp-block-paragraph">By contrast, Clorox generates cash from categories with sticky, recurring demand. Cleaning products, cat litter, water filtration, and salad dressings show up in households regardless of the broader economic climate.&nbsp;That&#8217;s&nbsp;the kind of revenue mix that supports a dividend through cycles.&nbsp;</p>



<h2 id="what-are-the-biggest-risks-for-clorox-stock" class="wp-block-heading">What Are the Biggest Risks for Clorox Stock?&nbsp;</h2>



<p class="wp-block-paragraph">Clorox&nbsp;isn&#8217;t&nbsp;without issues. The company recently announced a simplified operating structure aimed at accelerating growth. The board is also running a comprehensive CEO search.&nbsp;</p>



<p class="wp-block-paragraph">Leadership transitions can be&nbsp;bumpy. CLX has a 52-week range that has seen yields swing between&nbsp;roughly 4%&nbsp;and 7.3%. That tells&nbsp;you&nbsp;sentiment has been choppy.&nbsp;</p>



<p class="wp-block-paragraph">Even so, the math holds. CLX trades near $94 with a beta of 0.645, meaning it moves less than the broader market. The five-year average yield of 3.31% sits well below today&#8217;s level, so income buyers are getting paid more than usual to wait.&nbsp;</p>



<h2 id="should-investors-buy-clorox-or-kraft-heinz" class="wp-block-heading">Should Investors Buy Clorox or Kraft Heinz?&nbsp;</h2>



<p class="wp-block-paragraph">The ranch wars make for a fun headline. The dividend story is the real signal.&nbsp;</p>



<p class="wp-block-paragraph">KHC&#8217;s&nbsp;nearly 7%&nbsp;yield reflects a stock the market&nbsp;doesn&#8217;t&nbsp;trust. CLX&#8217;s 5%-plus yield is paired with a 47-year&nbsp;track record&nbsp;of raising the payout. One is risk-as-reward. The other is a Dividend Aristocrat&nbsp;that will be getting its Dividend King crown shortly.&nbsp;</p>



<p class="wp-block-paragraph">There&#8217;s&nbsp;also a behavioral edge. KHC&#8217;s higher yield will continue to attract reach-for-income buyers. CLX&#8217;s lower yield and longer streak attract reliability-first buyers. Over a five- to ten-year hold, the latter group has historically&nbsp;come out&nbsp;ahead.&nbsp;</p>



<p class="wp-block-paragraph">Kraft Heinz can give visitors a travel kit. Clorox owns the brand&nbsp;that passive income&nbsp;investors&nbsp;are actually trying to bring home.&nbsp;</p>



<p class="wp-block-paragraph"></p>
]]></content:encoded>
					
					<wfw:commentRss>https://cms.stocksearning.com/2026/06/clorox-better-buy-in-ranch-market/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Protect Your Portfolio with 3 High-Yielding Dividend ETFs</title>
		<link>https://cms.stocksearning.com/2026/04/protect-portfolio-with-dividend-etfs/</link>
					<comments>https://cms.stocksearning.com/2026/04/protect-portfolio-with-dividend-etfs/#respond</comments>
		
		<dc:creator><![CDATA[Ian Cooper]]></dc:creator>
		<pubDate>Mon, 27 Apr 2026 15:30:00 +0000</pubDate>
				<category><![CDATA[Evergreen]]></category>
		<category><![CDATA[ABBV]]></category>
		<category><![CDATA[AFL]]></category>
		<category><![CDATA[AMGN]]></category>
		<category><![CDATA[AVGO]]></category>
		<category><![CDATA[BRK.B]]></category>
		<category><![CDATA[CAT]]></category>
		<category><![CDATA[CLX]]></category>
		<category><![CDATA[CSCO]]></category>
		<category><![CDATA[CVX]]></category>
		<category><![CDATA[GD]]></category>
		<category><![CDATA[HD]]></category>
		<category><![CDATA[HRL]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[JPM]]></category>
		<category><![CDATA[KO]]></category>
		<category><![CDATA[MRK]]></category>
		<category><![CDATA[NOBL]]></category>
		<category><![CDATA[PFE]]></category>
		<category><![CDATA[PNR]]></category>
		<category><![CDATA[SCHD]]></category>
		<category><![CDATA[SCHV]]></category>
		<category><![CDATA[UPS]]></category>
		<category><![CDATA[wmt]]></category>
		<category><![CDATA[XOM]]></category>
		<guid isPermaLink="false">https://cms.stocksearning.com/?p=1793</guid>

					<description><![CDATA[In uncertain markets, dividend ETFs —especially those emphasizing companies with long histories of growing payouts—can help anchor your portfolio.]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">If you’re looking for safety—and income— dividend ETFs, showcasing Dividend Aristocrats and Dividend Kings, are a great place to start.</p>



<div class="wp-block-rank-math-toc-block" id="rank-math-toc"><h2>Table of Contents</h2><nav><ul><li><a href="#a-pure-play-on-dividend-aristocrats">A Pure Play on Dividend Aristocrats</a></li><li><a href="#low-cost-exposure-to-high-quality-value-stocks">Low-Cost Exposure to High-Quality Value Stocks</a></li><li><a href="#high-yield-meets-dividend-growth-discipline">High Yield Meets Dividend Growth Discipline</a></li><li><a href="#dividend-et-fs-offer-stability-in-any-market">Dividend ETFs Offer Stability in Any Market</a></li></ul></nav></div>



<p class="wp-block-paragraph">Dividend Aristocrats are widely considered some of the highest-quality companies in the market. To earn this title, a company must have increased its dividend payouts for at least 25 consecutive years. Dividend Kings take that standard even further. These elite companies have raised their dividends for 50 years or more, proving their resilience across multiple economic cycles.</p>



<p class="wp-block-paragraph">What makes these companies particularly compelling is their ability to perform in virtually any environment. Whether facing inflation, recessions, rising interest rates, market crashes, or economic booms, they have consistently rewarded shareholders with growing income. That kind of durability is rare—and valuable. It also reflects strong management teams, disciplined capital allocation, and business models built to withstand long-term pressure.</p>



<p class="wp-block-paragraph">Simply put, if a company can survive decades of economic uncertainty and still pay—and raise—dividends, it deserves attention.</p>



<p class="wp-block-paragraph">There’s just one drawback: there isn’t currently a dedicated ETF focused solely on Dividend Kings. That means investors looking for exposure must either purchase individual stocks or turn to ETFs that emphasize similar high-quality, dividend-growing companies.</p>



<p class="wp-block-paragraph">Here are three strong ETF options to consider.</p>



<h2 class="wp-block-heading" id="a-pure-play-on-dividend-aristocrats">A Pure Play on Dividend Aristocrats</h2>



<p class="wp-block-paragraph">The&nbsp;<strong>ProShares S&amp;P 500 Dividend Aristocrats ETF (BATS: NOBL)</strong>&nbsp;offers direct exposure to companies that have increased dividends for at least 25 consecutive years.</p>



<p class="wp-block-paragraph">With an expense ratio of 0.35% and a yield of approximately 2.05%, <a href="https://www.proshares.com/globalassets/proshares/fact-sheet/prosharesfactsheetnobl.pdf" target="_blank" rel="noopener">NOBL tracks the S&amp;P 500 Dividend Aristocrats Index</a>. The fund focuses on stable, high-quality businesses with long track records of dividend growth—many of which have been increasing payouts for 40 years or more.</p>



<p class="wp-block-paragraph">Its holdings include well-known companies such as&nbsp;<strong><a href="https://stocksearning.com/stocks/CAT/earnings-date">Caterpillar (NYSE: CAT)</a></strong>, <strong><a href="https://stocksearning.com/stocks/PNR/earnings-date">Pentair (NYSE: PNR)</a></strong>,&nbsp;<strong><a href="https://stocksearning.com/stocks/ABBV/earnings-date">AbbVie (NYSE: ABBV)</a></strong>,&nbsp;<strong><a href="https://stocksearning.com/stocks/AFL/earnings-date">Aflac (NYSE: AFL)</a></strong>,&nbsp;<strong><a href="https://stocksearning.com/stocks/GD/earnings-date">General Dynamics (NYSE: GD)</a></strong>,&nbsp;<a href="https://stocksearning.com/stocks/CLX/earnings-date"><strong>Clorox (NYSE: CLX</strong>)</a>,<strong>&nbsp;<a href="https://stocksearning.com/stocks/wmt/earnings-datehttps://stocksearning.com/stocks/wmt/earnings-date">Walmart (NASDAQ: WMT)</a></strong>, and&nbsp;<strong><a href="https://stocksearning.com/stocks/HRl/earnings-date">Hormel Foods (NYSE: HRL)</a></strong>.</p>



<p class="wp-block-paragraph">These companies have demonstrated consistent performance and income reliability, making NOBL a strong choice for conservative, income-focused investors.</p>



<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="600" height="312" data-source="article-image" src="https://cms.stocksearning.com/wp-content/uploads/2026/04/NOBL_2026-04-27_11-00-11-600x312.png" alt="dividend ETFs - StockEarnings" class="wp-image-1800" srcset="https://cms.stocksearning.com/wp-content/uploads/2026/04/NOBL_2026-04-27_11-00-11-600x312.png 600w, https://cms.stocksearning.com/wp-content/uploads/2026/04/NOBL_2026-04-27_11-00-11-300x156.png 300w, https://cms.stocksearning.com/wp-content/uploads/2026/04/NOBL_2026-04-27_11-00-11-768x400.png 768w, https://cms.stocksearning.com/wp-content/uploads/2026/04/NOBL_2026-04-27_11-00-11.png 1160w" sizes="auto, (max-width: 600px) 100vw, 600px" /></figure>



<h2 class="wp-block-heading" id="low-cost-exposure-to-high-quality-value-stocks">Low-Cost Exposure to High-Quality Value Stocks</h2>



<p class="wp-block-paragraph">Another solid option is the&nbsp;<strong>Schwab U.S. Large Cap Value ETF (NYSEARCA: SCHV)</strong>, which focuses on large-cap value stocks.</p>



<p class="wp-block-paragraph">SCHV stands out for its ultra-low expense ratio of just 0.04%, making it one of the most cost-effective ETFs available. It also offers a yield of about 1.85% and provides exposure to a diversified basket of financially strong companies.</p>



<p class="wp-block-paragraph">Top holdings include&nbsp;<strong><a href="https://stocksearning.com/stocks/BRK.B/earnings-date">Berkshire Hathaway (NYSE: BRK.B)</a></strong>,&nbsp;<strong><a href="https://stocksearning.com/stocks/jnj/earnings-date">Johnson &amp; Johnson (NYSE: JNJ)</a></strong>,&nbsp;<strong><a href="https://stocksearning.com/stocks/xom/earnings-date">Exxon Mobil (NYSE: XOM)</a></strong>,&nbsp;<strong><a href="https://stocksearning.com/stocks/JPM/earnings-date">JPMorgan Chase (NYSE: JPM)</a></strong>,&nbsp;<strong><a href="https://stocksearning.com/stocks/hd/earnings-date">Home Depot (NYSE: HD)</a></strong>,&nbsp;<strong>AbbVie</strong>,&nbsp;<strong><a href="https://stocksearning.com/stocks/PFE/earnings-date">Pfizer (NYSE: PFE)</a></strong>, and&nbsp;<strong><a href="https://stocksearning.com/stocks/mrk/earnings-date">Merck &amp; Co. (NYSE: MRK)</a></strong>. </p>



<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="600" height="312" data-source="article-image" src="https://cms.stocksearning.com/wp-content/uploads/2026/04/SCHV_2026-04-27_11-01-00-600x312.png" alt="dividend ETFs - StockEarnings" class="wp-image-1801" srcset="https://cms.stocksearning.com/wp-content/uploads/2026/04/SCHV_2026-04-27_11-01-00-600x312.png 600w, https://cms.stocksearning.com/wp-content/uploads/2026/04/SCHV_2026-04-27_11-01-00-300x156.png 300w, https://cms.stocksearning.com/wp-content/uploads/2026/04/SCHV_2026-04-27_11-01-00-768x400.png 768w, https://cms.stocksearning.com/wp-content/uploads/2026/04/SCHV_2026-04-27_11-01-00.png 1160w" sizes="auto, (max-width: 600px) 100vw, 600px" /></figure>



<h2 class="wp-block-heading" id="high-yield-meets-dividend-growth-discipline">High Yield Meets Dividend Growth Discipline</h2>



<p class="wp-block-paragraph">The&nbsp;<strong>Schwab U.S. Dividend Equity ETF (NYSEARCA: SCHD)</strong>&nbsp;is another popular choice among income investors. With an expense ratio of 0.06% and a yield of roughly 3.5%, SCHD tracks the Dow Jones U.S. Dividend 100 Index. The ETF focuses on companies with strong fundamentals, sustainable dividends, and a history of consistent payouts.</p>



<p class="wp-block-paragraph">Its holdings include industry leaders such as&nbsp;<strong><a href="https://stocksearning.com/stocks/amgn/earnings-date">Amgen (NASDAQ: AMGN)</a></strong>,&nbsp;<strong>AbbVie</strong>,&nbsp;<strong>Home Depot</strong>,&nbsp;<strong><a href="https://stocksearning.com/stocks/csco/earnings-date">Cisco Systems (NASDAQ; CSCO)</a></strong>,&nbsp;<strong><a href="https://stocksearning.com/stocks/avgo/earnings-date">Broadcom (NASDAQ: AVGO)</a></strong>,&nbsp;<strong><a href="https://stocksearning.com/stocks/cvx/earnings-date">Chevron Corporation (NYSE: CVX)</a></strong>,&nbsp;<strong><a href="https://stocksearning.com/stocks/ups/earnings-date">United Parcel Service (NYSE: UPS)</a></strong>, and&nbsp;<strong><a href="https://stocksearning.com/stocks/KO/earnings-date">The Coca-Cola Company (NYSE: KO)</a></strong>.</p>



<p class="wp-block-paragraph">SCHD is particularly appealing for investors seeking a blend of income, quality, and long-term growth potential.</p>



<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="600" height="312" data-source="article-image" src="https://cms.stocksearning.com/wp-content/uploads/2026/04/SCHD_2026-04-27_11-01-36-600x312.png" alt="Dividend ETFs - StockEarnings" class="wp-image-1802" srcset="https://cms.stocksearning.com/wp-content/uploads/2026/04/SCHD_2026-04-27_11-01-36-600x312.png 600w, https://cms.stocksearning.com/wp-content/uploads/2026/04/SCHD_2026-04-27_11-01-36-300x156.png 300w, https://cms.stocksearning.com/wp-content/uploads/2026/04/SCHD_2026-04-27_11-01-36-768x400.png 768w, https://cms.stocksearning.com/wp-content/uploads/2026/04/SCHD_2026-04-27_11-01-36.png 1160w" sizes="auto, (max-width: 600px) 100vw, 600px" /></figure>



<h2 class="wp-block-heading" id="dividend-et-fs-offer-stability-in-any-market">Dividend ETFs Offer Stability in Any Market</h2>



<p class="wp-block-paragraph">In uncertain markets, stability and income become even more important. Dividend-focused ETFs—especially those emphasizing companies with long histories of growing payouts—can help anchor your portfolio.</p>



<p class="wp-block-paragraph">These funds don’t just provide income—they offer exposure to businesses that have proven their ability to navigate inflation, recessions, and shifting interest rate environments. That kind of consistency can reduce volatility while still allowing for long-term capital appreciation.</p>



<p class="wp-block-paragraph">While no ETF is exclusively dedicated to Dividend Kings, funds like NOBL, SCHV, and SCHD give investors access to many of the same high-quality characteristics: strong balance sheets, disciplined management, and shareholder-friendly capital allocation.</p>



<p class="wp-block-paragraph">For investors looking to balance risk and reward, these ETFs can serve as a core portfolio holding—delivering both reliability and growth potential over time.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://cms.stocksearning.com/2026/04/protect-portfolio-with-dividend-etfs/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>2 Flu Season Stocks That Could Be the Right Prescription for Your Portfolio</title>
		<link>https://cms.stocksearning.com/2026/01/2-flu-season-stocks-to-buy-now/</link>
					<comments>https://cms.stocksearning.com/2026/01/2-flu-season-stocks-to-buy-now/#respond</comments>
		
		<dc:creator><![CDATA[Ian Cooper]]></dc:creator>
		<pubDate>Tue, 06 Jan 2026 12:00:00 +0000</pubDate>
				<category><![CDATA[Evergreen]]></category>
		<category><![CDATA[CLX]]></category>
		<category><![CDATA[CVS]]></category>
		<guid isPermaLink="false">https://cms.stocksearning.com/?p=771</guid>

					<description><![CDATA[With flu season nearing, it’s time to get flu shots and try your best to avoid germs. As anyone with a respiratory system will tell you, flu season isn’t fun.&#160; However, as any investor holding pharmacy and flu-related, coughing-and-sniffling remedy stocks will tell you, it can be one of the most predictable seasonal opportunities of [&#8230;]]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">With flu season nearing, it’s time to get flu shots and try your best to avoid germs. As anyone with a respiratory system will tell you, flu season isn’t fun.&nbsp;</p>



<div class="wp-block-rank-math-toc-block" id="rank-math-toc"><h2>Table of Contents</h2><nav><ul><li><a href="#clorox-clx-a-defensive-dividend-stock-with-seasonal-tailwinds">Clorox (CLX): A Defensive Dividend Stock With Seasonal Tailwinds</a></li><li><a href="#cvs-health-cvs-flu-season-drives-foot-traffic-and-cash-flow">CVS Health (CVS): Flu Season Drives Foot Traffic and Cash Flow</a></li><li><a href="#bottom-line-flu-season-stocks-can-offer-defensive-growth-and-income">Bottom Line: Flu Season Stocks Can Offer Defensive Growth and Income</a></li></ul></nav></div>



<p class="wp-block-paragraph">However, as any investor holding pharmacy and flu-related, coughing-and-sniffling remedy stocks will tell you, it can be one of the most predictable seasonal opportunities of the year.</p>



<p class="wp-block-paragraph">The flu is more than a public health issue. It’s a recurring demand driver for consumer staples, pharmacies, and healthcare providers. Every year, rising infection rates lead to higher spending on disinfectants, over-the-counter remedies, prescriptions, and in-store clinic visits. That makes flu season an underappreciated tailwind for certain defensive, dividend-paying stocks.</p>



<p class="wp-block-paragraph">For the 2023-2024 season, the CDC estimated&nbsp;40 million illnesses, 470,000 hospitalizations, and 28,000 deaths. For the 2024-2025 season, the CDC estimated&nbsp;9.3 million to 41 million illnesses, 120,000 to 710,000 hospitalizations, and 6,300 to 52,000 deaths.&nbsp;</p>



<p class="wp-block-paragraph">For the 2025-2026 season, cases are mounting.</p>



<p class="wp-block-paragraph">According to ABC News, the CDC estimates there have been at least <a href="https://abcnews.go.com/US/flu-activity-rises-sharply-us-75-million-illnesses/story?id=128765018" target="_blank" rel="noopener">7.5 million illnesses, 81,000 hospitalizations, and 3,100 deaths</a> from flu so far this season. At least<strong> </strong>20 states are reporting “very high” respiratory illness activity, spanning much of the Midwest, Northeast, and South.</p>



<p class="wp-block-paragraph">That backdrop creates a compelling case for investors looking to add defensive exposure with income. Two stocks that stand out heading into peak flu season are <strong><a href="https://stocksearning.com/stocks/CLX/earnings-date">The Clorox Company (NYSE: CLX)</a></strong> and <strong><a href="https://stocksearning.com/stocks/CVS/earnings-date">CVS Health Corp. (NYSE: CVS)</a></strong>.</p>



<h2 class="wp-block-heading" id="clorox-clx-a-defensive-dividend-stock-with-seasonal-tailwinds">Clorox (CLX): A Defensive Dividend Stock With Seasonal Tailwinds</h2>



<p class="wp-block-paragraph">Clorox is best known for its namesake disinfecting wipes and bleach products, but the company’s portfolio extends far beyond cleaning. Brands like Pine-Sol, Burt’s Bees, Glad, Hidden Valley, Kingsford, and Brita give Clorox broad exposure to everyday consumer spending.</p>



<p class="wp-block-paragraph">During flu season, however, Clorox’s cleaning and disinfecting products take center stage. Heightened awareness around germs typically leads to increased household and institutional spending on wipes, sprays, and surface cleaners—categories where Clorox commands strong brand loyalty and pricing power.</p>



<p class="wp-block-paragraph">From an income perspective, CLX is particularly compelling right now. Shares currently offer a dividend yield of approximately 4.9%, well above the company’s long-term average. That yield reflects not just generous shareholder returns, but also how far the stock has fallen.</p>



<p class="wp-block-paragraph">At around $101 per share, Clorox stock is deeply oversold relative to historical levels. Inflation-driven cost pressures and execution issues hurt sentiment over the last two years, but margins have begun to stabilize as pricing actions take hold and input costs moderate.</p>



<p class="wp-block-paragraph">Seasonality is another factor working in Clorox’s favor. Going back to 2021, CLX has frequently rallied during the fall and early winter months:</p>



<ul class="wp-block-list">
<li><strong>2022:</strong> CLX climbed from roughly $141 in October to over $158</li>



<li><strong>2023:</strong> Shares ran from about $114 to $146</li>



<li><strong>2024:</strong> CLX advanced from around $153 to $163</li>
</ul>



<p class="wp-block-paragraph">The 2025 seasonal rally failed to materialize, leaving the stock lagging its typical pattern. That deviation may actually create opportunity, particularly if investors rotate into defensive names as economic uncertainty persists.</p>



<p class="wp-block-paragraph">For long-term investors, Clorox offers a blend of recession resistance, seasonal demand, and income stability. While it may not be a high-growth stock, CLX fits well for portfolios seeking yield and downside protection during volatile markets.</p>



<h2 class="wp-block-heading" id="cvs-health-cvs-flu-season-drives-foot-traffic-and-cash-flow">CVS Health (CVS): Flu Season Drives Foot Traffic and Cash Flow</h2>



<p class="wp-block-paragraph">CVS Health offers a different—but equally compelling—way to play flu season. As one of the largest pharmacy operators in the U.S., CVS sits at the intersection of prescriptions, vaccinations, clinics, and health insurance.</p>



<p class="wp-block-paragraph">Flu season directly boosts CVS’s core pharmacy business. Increased demand for flu shots, COVID boosters, antiviral prescriptions, and over-the-counter medications drives higher store traffic. That foot traffic often leads to incremental purchases across front-of-store items, improving overall revenue per visit.</p>



<p class="wp-block-paragraph">CVS’s MinuteClinic and HealthHUB locations further amplify this effect. These in-store clinics make CVS a convenient destination for flu testing, vaccinations, and basic care. Those services are in high demand during peak respiratory illness season.</p>



<p class="wp-block-paragraph">Despite these structural advantages, CVS stock has been under pressure. Concerns around reimbursement rates, integration of acquisitions, and healthcare cost trends have weighed on shares. However, that pessimism may be overdone.</p>



<p class="wp-block-paragraph">At current levels, CVS trades at a single-digit forward earnings multiple and offers a dividend yield north of 4%. Management has reiterated its commitment to the dividend, supported by strong operating cash flow from its pharmacy benefits management (PBM) and insurance segments.</p>



<p class="wp-block-paragraph">From a seasonal standpoint, CVS has historically performed well heading into and during flu season as investors anticipate higher prescription volumes and clinic utilization. While CVS isn’t a pure seasonal trade, flu season acts as a reliable catalyst that highlights the company’s recurring revenue model.</p>



<p class="wp-block-paragraph">For investors willing to tolerate near-term headlines, CVS offers a combination of value, income, and healthcare defensiveness that’s hard to ignore.</p>



<h2 class="wp-block-heading" id="bottom-line-flu-season-stocks-can-offer-defensive-growth-and-income">Bottom Line: Flu Season Stocks Can Offer Defensive Growth and Income</h2>



<p class="wp-block-paragraph">Flu season may be miserable for consumers, but it often creates predictable demand for certain healthcare and consumer staple companies. That demand can translate into stronger revenues, steadier cash flow, and more resilient stock performance during uncertain markets.</p>



<p class="wp-block-paragraph">Clorox provides exposure to household cleaning essentials with a historically high dividend yield and seasonal upside potential. CVS Health offers a broader healthcare platform that benefits from increased prescriptions, vaccinations, and clinic visits as flu cases rise.</p>



<p class="wp-block-paragraph">For investors looking to add defensive, dividend-paying stocks to their portfolios, flu season could be the right time to act—and these two stocks may offer the right prescription.</p>



<p class="wp-block-paragraph"></p>
]]></content:encoded>
					
					<wfw:commentRss>https://cms.stocksearning.com/2026/01/2-flu-season-stocks-to-buy-now/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
